Intellectus Partners’s Relay Therapeutics RLAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Sell	42,225 -1,700	-4%	-$15.2K	0.09%	222
2025 Q4	$372K	Sell	43,925 -12,500	-22%	-$89.2K	0.07%	212
2025 Q3	$295K	Sell	56,425 -5,000	-8%	-$19.1K	0.06%	237
2025 Q2	$213K	Hold	61,425	–	–	0.05%	259
2025 Q1	$161K	Hold	61,425	–	–	0.04%	256
2024 Q4	$253K	Sell	61,425 -6,250	-9%	-$34K	0.06%	238
2024 Q3	$479K	Hold	67,675	–	–	0.12%	187
2024 Q2	$441K	Sell	67,675 -1,585	-2%	-$10.8K	0.12%	181
2024 Q1	$575K	Buy	69,260 +19,400	+39%	+$189K	0.15%	174
2023 Q4	$549K	Sell	49,860 -700	-1%	-$5.91K	0.16%	167
2023 Q3	$425K	Buy	50,560 +2,000	+4%	+$21.5K	0.13%	187
2023 Q2	$610K	Buy	48,560 +21,675	+81%	+$270K	0.18%	159
2023 Q1	$443K	Sell	26,885 -1,900	-7%	-$34.1K	0.14%	180
2022 Q4	$430K	Buy	28,785 +2,800	+11%	+$53.6K	0.15%	175
2022 Q3	$581K	Buy	25,985 +1,725	+7%	+$37.9K	0.21%	133
2022 Q2	$406K	Buy	24,260 +1,790	+8%	+$38.4K	0.14%	181
2022 Q1	$673K	Sell	22,470 -3,700	-14%	-$89.8K	0.2%	130
2021 Q4	$804K	Sell	26,170 -8,024	-23%	-$254K	0.2%	131
2021 Q3	$1.08M	Buy	34,194 +150	+0.4%	+$5.05K	0.26%	104
2021 Q2	$1.25M	Buy	34,044 +9,189	+37%	+$303K	0.28%	93
2021 Q1	$859K	Buy	24,855 +15,105	+155%	+$656K	0.24%	129
2020 Q4	$405K	Buy	+9,750	New	+$441K	0.12%	175

Other funds holding RLAY